FDA approves weight management drug

The U.S. Food and Drug Administration has approved Contrave as a treatment for chronic weight management. Contrave is a combination of two FDA-approved drugs, naltrexone and bupropion, in an extended-release formulation.

Nursing homes can assess nutritional status by measuring residents' calves rather than body mass index, researchers find


Nursing home caregivers can get a good idea of residents' nutritional status by measuring their calves rather than calculating their body mass index with height and weight, according to recently published research findings.